People: Halozyme Therapeutics Inc (HALO.A)

HALO.A on American Stock Exchange

7.97USD
17 May 2013
Price Change (% chg)

$-0.01 (-0.11%)
Prev Close
$7.98
Open
$8.42
Day's High
$8.42
Day's Low
$7.91
Volume
14,668
Avg. Vol
11,679
52-wk High
$9.88
52-wk Low
$3.92

Search Stocks

Shaffer, James 

Brief Biography

Mr. James P. Shaffer is Vice President, Chief Commercial Officer of Halozyme Therapeutics, Inc. Mr. James Shaffer joined Halozyme in 2011 with over 23 years of Commercial Operations experience. From 2007 to 2011, he was at Clinical Data, Inc. where he was responsible for Marketing, Sales, Business Development and Manufacturing with his most recent position as Executive Vice President and Chief Commercial Officer. Prior to Clinical Data, he worked at New River Pharmaceuticals, Prestwick Pharmaceuticals, InterMune and GSK. He has experience in variety of pharmaceutical companies in the areas of Neurology, Psychiatry, Oncology, GI and Pulmonary Care with specialized experience in developing and marketing genetic tests in Oncology and Cardiology. Mr. Shaffer received his M.B.A. in Marketing and B.S. in Economics from Ohio State University.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
155,705 -- 999,120 1,154,820

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Kenneth Kelley

--

Gregory Frost

683,524

Kurt Gustafson

754,393

H. Michael Shepard

690,178

Jean Liu

1,047,540

James Shaffer

1,154,820
As Of 30 Dec 2011
Search Stocks